Galectin Therapeutics, Inc. (GALT)
2.43
+0.03
(+1.25%)
USD |
NASDAQ |
Jun 09, 16:00
2.32
-0.11
(-4.53%)
After-Hours: 17:21
Galectin Therapeutics Market Cap : 160.03M for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.737B |
| Alnylam Pharmaceuticals, Inc. | 39.73B |
| Savara, Inc. | 1.009B |
| Vericel Corp. | 1.888B |
| Biogen, Inc. | 29.40B |
Market Cap Related Metrics
| Price | 2.43 |
| Earnings Yield | -16.87% |